Salud financiera de hoja de balance de Essex Bio-Technology
Salud financiera controles de criterios 6/6
Essex Bio-Technology tiene un patrimonio de accionistas total de HK$2.0B y una deuda total de HK$306.5M, lo que sitúa su ratio deuda-patrimonio en 15.2%. Sus activos y pasivos totales son HK$3.0B y HK$950.3M respectivamente. El BAIT de Essex Bio-Technology es de HK$321.4M, por lo que su ratio de cobertura de intereses es de -46.3. Tiene efectivo e inversiones a corto plazo que ascienden a HK$600.6M.
Información clave
15.2%
Ratio deuda-patrimonio
HK$306.54m
Deuda
| Ratio de cobertura de intereses | -46.3x |
| Efectivo | HK$600.62m |
| Patrimonio | HK$2.02b |
| Total pasivo | HK$950.33m |
| Activos totales | HK$2.97b |
Actualizaciones recientes sobre salud financiera
Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet
Dec 07
Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly
Dec 07Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?
Jun 22Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly
Jun 29Is Essex Bio-Technology (HKG:1061) A Risky Investment?
Mar 31Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly
Dec 13
Recent updates
Essex Bio-Technology Limited (HKG:1061) Surges 29% Yet Its Low P/E Is No Reason For Excitement
Oct 09Essex Bio-Technology's (HKG:1061) Upcoming Dividend Will Be Larger Than Last Year's
Aug 29Essex Bio-Technology Limited's (HKG:1061) Low P/E No Reason For Excitement
May 06Calculating The Fair Value Of Essex Bio-Technology Limited (HKG:1061)
Mar 21Essex Bio-Technology (HKG:1061) Has A Pretty Healthy Balance Sheet
Dec 07Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly
Dec 07Essex Bio-Technology (HKG:1061) Is Due To Pay A Dividend Of HK$0.04
Aug 25Is Essex Bio-Technology (HKG:1061) Using Too Much Debt?
Jun 22Essex Bio-Technology (HKG:1061) Has Announced That It Will Be Increasing Its Dividend To HK$0.055
May 02Essex Bio-Technology (HKG:1061) Will Pay A Larger Dividend Than Last Year At HK$0.055
Mar 30Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly
Jun 29Is Essex Bio-Technology (HKG:1061) A Risky Investment?
Mar 31If You Had Bought Essex Bio-Technology (HKG:1061) Stock Five Years Ago, You Could Pocket A 40% Gain Today
Mar 13How Many Essex Bio-Technology Limited (HKG:1061) Shares Did Insiders Buy, In The Last Year?
Feb 15Do Institutions Own Essex Bio-Technology Limited (HKG:1061) Shares?
Jan 25Essex Bio-Technology Limited's (HKG:1061) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Jan 04Essex Bio-Technology (HKG:1061) Seems To Use Debt Quite Sensibly
Dec 13Why Essex Bio-Technology's (HKG:1061) CEO Pay Matters
Nov 23Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (HK$1.4B) de 1061 superan a sus pasivos a corto plazo (HK$824.2M).
Pasivo a largo plazo: Los activos a corto plazo de 1061 (HK$1.4B) superan a sus pasivos a largo plazo (HK$126.1M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 1061 tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de 1061 ha pasado de 22.1% a 15.2% en los últimos 5 años.
Cobertura de la deuda: La deuda de 1061 está bien cubierta por el flujo de caja operativo (103%).
Cobertura de intereses: 1061 gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.